Justin M. Hall is an extremely accomplished independent financial analyst with more than a decade of experience in the financial markets. He consistently provides expertise to a variety of financial clients and is known for his successful market predictions. Between 2010 and 2014 Justin made 239 specific market recommendations via his online subscription service with an 80% accuracy rate. He has produced enduring results for a variety of clients including those who trade stocks, invest their own money, desire personal wealth management, and institutional investors. But more than an analyst, Justin is a person who influences and persuades, whose judgement is well respected and highly trusted, and whose opinion is sought by those searching for financial and investment advice. Justin received his undergraduate degree from Indiana State University and attended law school at Indiana University. His desire to serve the financial and investment needs of individual clients led him to start Rx Investors.com, an online subscription service that connected individual investors with his expert analysis. Subscribers from all over the world utilized Justin’s advice to generate market income and grow their individual portfolios. Many of these subscribers and clients continued to seek Justin’s analysis and advice for many years, appreciating his unique perspective on the financial industry. A variety of financial outlets have recognized Justin’s expertise and highlighted his work including the Orange County Business Journal, Seeking Alpha, and Zack’s Investment Research. These industry connections have allowed Justin to lend his expert advice to others and expand his influence.
Kavout applies advances in artificial intelligence, big data technologies and machine learning to make finding, screening and analyzing investment opportunities easy and efficient. Ultimately, Kavout’s message to individual investors is that anyone can invest and control their own financial future if they have the right tools at their disposal – namely, the sophisticated investment research platform that Kavout offers. Due to its innovative model, highly comprehensive and transparent approach and delivery of real value to individual investors, Kavout is positioned to become a global leader in intelligent investment platforms.
My investment thesis is that Cancer will be cured in this decade and the
Magnificent Seven will move us toward the goal CTIX NWBO PCYC THLD SNTA IMUC SBFM
The next Wave will be Regenerative Medicine and a group of biotechs I call the
Cell Biology Seven will lead that wave. ISCO is now the leader of that group and
may become the dominant supplier to others in the field in the same manner that
MSFT came to dominate computer operating systems in prior decades.
The other six are BTX MEDS NNVC BCLI ARWR SRPT
Farah Merchant, Capital Markets Advisor, Proactive Capital Group
ProActive Capital Group, LLC (“PCG”) is dedicated to the discovery and creation of shareholder value for public companies. PCG has specific experience with life science, high technology and international companies.
PCG provides its clients with capital market advisory, strategic communication and multimedia marketing services. We adapt these services to each client’s particular needs to successfully reach and influence key capital market participants in order to maximize shareholder value.
PCG’s capital market advisory services include overall investor strategy development to increase and leverage investor awareness, visibility & credibility.
PCG’s strategic communications services leverage digital media channels to further increase awareness to all key constituents.
PCG’s multimedia marketing services include direct mail, email marketing, investor presentation production, video production and website development
Capital Markets consultant and active investor in the emerging life science space. Tenured futures trader. Able to provide access to a pool of investors and traders throughout the US and UK. ProActive Capital, a capital markets advisory firm that makes direct investments and provides advisory services into public and private life science companies. Areas of focus include; capital introduction, shareholder management, communications and investor outreach.
Interested in technology and financial markets. Undergrad in engineering, MS in Comp Sci and an MBA in finance. Building tools for individual investors to make more informed decisions about the stocks and mutual funds they choose.
Identify businesses that have long-term sustainable growth opportunities and are trading at a good value.